Daniel Robertson, Ph.D.: Discovery with Purpose: Understanding Disease (Health) through Information Capture, Integration, and Analytics
Friday, February 17 at 12:30 p.m. in IT 252
About this talk
The initial part of this presentation will present an overview of the drug discovery process and the computational and informatics capabilities to support these pre-clinical efforts. The second section of this presentation will provide an overview more recent collaborative efforts to leverage regional data and organizations to better understand human health. Lessons learned along this journey will be highlighted.
About Daniel H. Robertson
Daniel H. Robertson, a proven and experienced technical leader in information technology (IT), computational science and research, is a Visiting Research Fellow at the IBRI focused on defining and developing the Institute’s computational analytics and data science capabilities. Dr. Robertson is on a loaned executive program from Eli Lilly and Company where he recently served as Senior Director of Research IT and led the IT team supporting discovery systems and processes across six global research sites and nine functional/therapeutic areas. In his leadership role, Dr. Robertson was instrumental in delivering emerging technology and analyses through informatics resources, enhancing support for big data storage and analysis, and transforming IT support for Open Innovation Drug Discovery program to a high-performing DevOps team, which was recognized with an InformationWeek 500 award. Dr. Robertson joined Lilly as a research scientist at Lilly Research Laboratories.
Dr. Robertson earned his PhD in physical chemistry from Florida State University and his Bachelor of Science degree in chemistry, graduating Summa Cum Laude, from Florida Southern College. After earning his PhD., Dr. Robertson served as an NRC/NRL Postdoctoral Research Associate at the Naval Research Laboratory in Washington, D.C., and then held several positions at IUPUI from 1993 through 2000. He last served as Associate Scientist and Director of Technical and Administrative Services and Manager of the Facility for Computational Molecular Science at IUPUI before joining Eli Lilly and Company in 2000.
Dr. Robertson has published 67 papers in refereed journals, authored three invited book chapters, and conducted more than 65 professional/technical presentations. He has been honored with multiple awards from Eli Lilly and Company and IUPUI, and is a member of the American Chemical Society, American Physical Society and physics and mathematics honoraries.